IML - INNOVATIVE MEDICINE FOR LUXEMBOURG

D16

Description

IML is the association of the biopharmaceutical industries active in Luxembourg and brings together the expertise of more than 60 laboratories involved in the research and development of innovative medicines. Our members account for around 90% of medicines imported into Luxembourg. IML was created in 2011 on the initiative of the Luxembourg health authorities.